Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials
Lisa K. Stamp, Christopher Frampton, Melanie Birger Morillon, et al.
The Lancet Rheumatology (2021) Vol. 4, Iss. 1, pp. e53-e60
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Comparative Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations
Natalie McCormick, Chio Yokose, Jie Wei, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 8, pp. 1067-1080
Closed Access | Times Cited: 29
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial
Lisa K. Stamp, Anne Horne, Borislav Mihov, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 12, pp. 1626-1634
Closed Access | Times Cited: 25
A glance into the future of gout
Francisca Sivera, Mariano Andrés, Nicola Dalbeth
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 27
Moving urate-lowering therapy in gout beyond guideline recommendations
Lisa K. Stamp, Nicola Dalbeth
Seminars in Arthritis and Rheumatism (2024) Vol. 65, pp. 152358-152358
Open Access | Times Cited: 5
Relationship between serum urate and changes in dual-energy CT monosodium urate crystal volume over 1 year in people with gout: an individual participant data analysis
Brooke Kelly, Greg Gamble, Anne Horne, et al.
Annals of the Rheumatic Diseases (2024) Vol. 84, Iss. 1, pp. 136-142
Closed Access | Times Cited: 4
Management and Cure of Gouty Arthritis
Sarah Keller, Brian F. Mandell
Rheumatic Disease Clinics of North America (2022) Vol. 48, Iss. 2, pp. 479-492
Closed Access | Times Cited: 17
Allopurinol use and risk of multiple sclerosis
Ida M. Heerfordt, Elisabeth Framke, Josefine Windfeld‐Mathiasen, et al.
Multiple Sclerosis and Related Disorders (2025), pp. 106299-106299
Open Access
Treat to Target in Gout Management: A Critical Reappraisal of Current Strategies
Anusha Moses, Martijn A. H. Oude Voshaar, Mart van de Laar, et al.
Gout Urate and Crystal Deposition Disease (2025) Vol. 3, Iss. 1, pp. 3-3
Open Access
Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial
Abdul Abdellatif, Lin Zhao, K. Obermeyer, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Urate lowering therapy in primary care: rheum for improvement
Emilie Schurenberg, Edward M. Huddleston, Kenneth G. Saag
Exploration of Musculoskeletal Diseases (2025)
Closed Access
Sodium-Glucose Cotransporter-2 Inhibitors vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving Metformin
Natalie McCormick, Chio Yokose, Na Lu, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 6, pp. 650-650
Closed Access | Times Cited: 3
Treat-to-target or treat-to-dissolve strategy to improve gout treatment
Pascal Richette, Nicola Dalbeth
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 7, pp. 393-394
Closed Access | Times Cited: 3
Analysis of Gout Remission Definitions in a Randomized Controlled Trial of Colchicine Prophylaxis for People With Gout Initiating Allopurinol
Adwoa Dansoa Tabi‐Amponsah, Lisa K. Stamp, Anne Horne, et al.
The Journal of Rheumatology (2024) Vol. 51, Iss. 11, pp. 1135-1140
Closed Access | Times Cited: 3
Critical appraisal of serum urate targets in the management of gout
Lisa K. Stamp, Nicola Dalbeth
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 10, pp. 603-609
Closed Access | Times Cited: 14
Predicting gout flares in people starting allopurinol using the start‐low go‐slow dose escalation strategy
Lisa K. Stamp, Anne Horne, Borislav Mihov, et al.
Arthritis Care & Research (2024) Vol. 76, Iss. 10, pp. 1371-1378
Open Access | Times Cited: 2
Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review
Adwoa Dansoa Tabi‐Amponsah, Sarah Stewart, Graham Hosie, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 779-779
Open Access | Times Cited: 5
Surrogate endpoints: a key concept in clinical epidemiology
Robin Christensen, Oriana Ciani, Anthony Muchai Manyara, et al.
Journal of Clinical Epidemiology (2023) Vol. 167, pp. 111242-111242
Open Access | Times Cited: 4
Serum Urate and Its Association With Gout Flares
Angelo Gaffo
JAMA (2024) Vol. 331, Iss. 5, pp. 393-393
Closed Access | Times Cited: 1
Serum Urate as a Surrogate Outcome for Gout Flares: Where Do We Stand Today?
Lisa K. Stamp, Robin Christensen, Melanie Birger Morillon
Gout Urate and Crystal Deposition Disease (2024) Vol. 2, Iss. 1, pp. 70-76
Open Access | Times Cited: 1
What Is Allopurinol Failure and What Should We Do About It?
Lisa K. Stamp, Nicola Dalbeth
The Journal of Rheumatology (2024), pp. jrheum.2024-0144
Open Access | Times Cited: 1
The experiences and perspectives of people with gout on urate self‐monitoring
Toni J. F. Michael, Jian S. Chan, Stephen Hughes, et al.
Health Expectations (2024) Vol. 27, Iss. 3
Open Access | Times Cited: 1
Patient Experience with Chronic Refractory Gout and Its Impact on Health-Related Quality of Life: Literature Review and Qualitative Analysis
Vibeke Strand, Michael H. Pillinger, Abiola Oladapo, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 5, pp. 1271-1290
Open Access | Times Cited: 1
Safety and efficacy of gout treatments in people with renal impairment
Hamish Farquhar, Angelo Gaffo, Lisa K. Stamp
Exploration of Musculoskeletal Diseases (2024) Vol. 2, Iss. 5, pp. 360-374
Open Access | Times Cited: 1
Year in Review: Gout Clinical Research
Mariana Urquiaga, Angelo Gaffo
Gout Urate and Crystal Deposition Disease (2023) Vol. 1, Iss. 1, pp. 37-48
Open Access | Times Cited: 3
Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group
Melanie Birger Morillon, Robin Christensen, Jasvinder A. Singh, et al.
Seminars in Arthritis and Rheumatism (2021) Vol. 51, Iss. 6, pp. 1378-1385
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top